ConductScience.org, home

Paper42164352

DARS2 serves as an independent prognostic factor and participates in multiple biological processes in bladder urothelial carcinoma.

Qiu R and 8 others. Transl Androl Urol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. DARS2 serves as an independent prognostic factor and participates in multiple biological processes in bladder urothelial carcinoma. Papers, record 42164352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42164352

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
DARS2 serves as an independent prognostic factor and participates in multiple biological processes in bladder urothelial carcinoma.
PubMed
Journal
Transl Androl Urol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qiu RRenhui
2Lin TTaofa
3Dong LLi
4He MMiao
5Deng SShilong
6Xu SShengfa
7Deng ZZhen
8Deng CCheng
9Guo CChunyu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137626419DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.J Transl Med2023https://conductscience.org/library/papers/37626419PubMed
240294008Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.Cancer Discov2025https://conductscience.org/library/papers/40294008PubMed
338299141Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor.Front Immunol2023https://conductscience.org/library/papers/38299141PubMed
440185339Aminolevulinate/iron exposure elicited Nrf-2-mediated cytoprotection in DARS2 deficient fibroblasts with impaired energy and antioxidant metabolisms.Biochim Biophys Acta Mol Basis Dis2025https://conductscience.org/library/papers/40185339PubMed
533850871Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein.Ann Transl Med2021https://conductscience.org/library/papers/33850871PubMed
640683603Restoration of N-glycosylation via leucine-activated leucyl-tRNA synthetase 1 overcomes chemoresistance in intrahepatic cholangiocarcinoma.J Hepatol2026https://conductscience.org/library/papers/40683603PubMed
740301173The tumor-promoting role of methionyl-tRNA synthetase 1 in ovarian cancer and its potential mechanisms.Med Oncol2025https://conductscience.org/library/papers/40301173PubMed
838582099Integrative Single Cell Atlas Revealed Intratumoral Heterogeneity Generation from an Adaptive Epigenetic Cell State in Human Bladder Urothelial Carcinoma.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38582099PubMed
940754534Mitochondrial metabolism and cancer therapeutic innovation.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40754534PubMed
1041551149Prokaryotic organelle mitochondria drive tumorigenesis: "the original sin".Front Oncol2025https://conductscience.org/library/papers/41551149PubMed
1140172969DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40172969PubMed
1236937395Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer.Front Oncol2023https://conductscience.org/library/papers/36937395PubMed
1338418280Mitochondrial dysfunction in lipid processing and gastrointestinal disorders.Trends Endocrinol Metab2024https://conductscience.org/library/papers/38418280PubMed
1438382106Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.Aging (Albany NY)2024https://conductscience.org/library/papers/38382106PubMed
1540777041Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.Front Immunol2025https://conductscience.org/library/papers/40777041PubMed
1634239534Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer.Front Genet2021https://conductscience.org/library/papers/34239534PubMed
1741035672Identification of amino acid metabolism-related gene Leucyl-tRNA synthetase 1 (LARS1) as a potential prognostic and therapeutic target in hepatocellular carcinoma.Front Oncol2025https://conductscience.org/library/papers/41035672PubMed
1841639505The role of Alanyl-tRNA synthetase 1 lactylation in tumors and other diseases.Discov Oncol2026https://conductscience.org/library/papers/41639505PubMed
1940485603Mechanistic Foundations of KRAS-Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40485603PubMed
2040911595Restoring mitochondrial quantity and quality to reverse the Warburg effect and drive neuroblastoma differentiation.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40911595PubMed

See all 35 referencesDownload CSV of references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
DARS255157PubTator's text mininghttps://conductscience.org/library/genes/55157NCBI Gene
RET5979PubTator's text mininghttps://conductscience.org/library/genes/5979NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42164352

GET https://conductscience.org/api/papers/v1/42164352/references?page=2